Cargando…
Recommendations on how to ensure the safety and effectiveness of biosimilars in Latin America: a point of view
The use of biotechnology-derived medicines has significantly increased in recent decades. Although biosimilars undergo rigorous characterization as well as clinical studies to document their safety and effectiveness, they are highly complex molecules and small changes in the purification and product...
Autores principales: | Pineda, Carlos, Caballero-Uribe, Carlo V., de Oliveira, Marcia Gonclaves, Lipszyc, Pedro Saul, Lopez, Jose Julian, Mataos Moreira, Marcelo Mario, Azevedo, Valderilio Feijo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365179/ https://www.ncbi.nlm.nih.gov/pubmed/25673060 http://dx.doi.org/10.1007/s10067-015-2887-0 |
Ejemplares similares
-
Practical Guidance on Biosimilars, With a Focus on Latin America: What Do Rheumatologists Need to Know?
por: Azevedo, Valderilio Feijó, et al.
Publicado: (2019) -
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
por: Mysler, Eduardo, et al.
Publicado: (2021) -
The biosimilars journey: current status and ongoing challenges
por: Kos, Igor Age, et al.
Publicado: (2018) -
Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists
por: Urbano, Paulo César Martins, et al.
Publicado: (2014) -
Challenges and opportunities for diagnosis and treatment of rheumatoid arthritis in Latin America
por: Pineda, Carlos, et al.
Publicado: (2015)